These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 22932671)

  • 1. Antimicrobial drug use and macrolide-resistant Streptococcus pyogenes, Belgium.
    Van Heirstraeten L; Coenen S; Lammens C; Hens N; Goossens H; Malhotra-Kumar S
    Emerg Infect Dis; 2012 Sep; 18(9):1515-8. PubMed ID: 22932671
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Unusual resistance patterns in macrolide-resistant Streptococcus pyogenes harbouring erm(A).
    Malhotra-Kumar S; Mazzariol A; Van Heirstraeten L; Lammens C; de Rijk P; Cornaglia G; Goossens H
    J Antimicrob Chemother; 2009 Jan; 63(1):42-6. PubMed ID: 18952616
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Differences in the DNA sequences in the upstream attenuator region of erm(A) in clinical isolates of Streptococcus pyogenes and their correlation with macrolide/lincosamide resistance.
    Doktor SZ; Shortridge V
    Antimicrob Agents Chemother; 2005 Jul; 49(7):3070-2. PubMed ID: 15980403
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Plasmid-Borne erm(T) from invasive, macrolide-resistant Streptococcus pyogenes strains.
    Woodbury RL; Klammer KA; Xiong Y; Bailiff T; Glennen A; Bartkus JM; Lynfield R; Van Beneden C; Beall BW;
    Antimicrob Agents Chemother; 2008 Mar; 52(3):1140-3. PubMed ID: 18180360
    [TBL] [Abstract][Full Text] [Related]  

  • 5. mef(A) is the predominant macrolide resistance determinant in Streptococcus pneumoniae and Streptococcus pyogenes in Germany.
    Bley C; van der Linden M; Reinert RR
    Int J Antimicrob Agents; 2011 May; 37(5):425-31. PubMed ID: 21419605
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Emergence of macrolide-resistant Streptococcus pyogenes strains in French children.
    Bingen E; Bidet P; Mihaila-Amrouche L; Doit C; Forcet S; Brahimi N; Bouvet A; Cohen R
    Antimicrob Agents Chemother; 2004 Sep; 48(9):3559-62. PubMed ID: 15328126
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular characterization of macrolide resistance mechanisms among Streptococcus pneumoniae and Streptococcus pyogenes isolated from the PROTEKT 1999-2000 study.
    Farrell DJ; Morrissey I; Bakker S; Felmingham D
    J Antimicrob Chemother; 2002 Sep; 50 Suppl S1():39-47. PubMed ID: 12239227
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of multiple macrolide- and lincosamide-resistant strains of Streptococcus pyogenes from patients in the Boston area.
    Hasenbein ME; Warner JE; Lambert KG; Cole SE; Onderdonk AB; McAdam AJ
    J Clin Microbiol; 2004 Apr; 42(4):1559-63. PubMed ID: 15071004
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution of macrolide resistance mechanisms in Bulgarian clinical isolates of Streptococcus pyogenes during the years of 2013-2016.
    Muhtarova AA; Gergova RT; Mitov IG
    J Glob Antimicrob Resist; 2017 Sep; 10():238-242. PubMed ID: 28735056
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Macrolide and tetracycline resistance and emm type distribution of Streptococcus pyogenes isolates recovered from Turkish patients.
    Dundar D; Sayan M; Tamer GS
    Microb Drug Resist; 2010 Dec; 16(4):279-84. PubMed ID: 20624096
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Macrolide- and telithromycin-resistant Streptococcus pyogenes, Belgium, 1999-2003.
    Malhotra-Kumar S; Lammens C; Chapelle S; Wijdooghe M; Piessens J; Van Herck K; Goossens H
    Emerg Infect Dis; 2005 Jun; 11(6):939-42. PubMed ID: 15963292
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Current status of antimicrobial susceptibility of clinical isolates of Streptococcus pyogenes in Japan: report of a countrywide surveillance study.
    Hotomi M; Billal DS; Shimada J; Yamauchi K; Fujihara K; Yamanaka N;
    J Infect Chemother; 2005 Feb; 11(1):48-51. PubMed ID: 15729489
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prevalence of Streptococcus invasive locus (sil) and its relationship with macrolide resistance among group A Streptococcus strains.
    Billal DS; Hotomi M; Shimada J; Fujihara K; Ubukata K; Sugita R; Yamanaka N
    J Clin Microbiol; 2008 Apr; 46(4):1563-4. PubMed ID: 18287313
    [No Abstract]   [Full Text] [Related]  

  • 14. Molecular analysis of Streptococcus pyogenes macrolide resistance of paediatric isolates during a 7 year period (2007-13).
    Michos A; Koutouzi FI; Tsakris A; Chatzichristou P; Koutouzis EI; Daikos GL; Stathi A; Syriopoulou VP
    J Antimicrob Chemother; 2016 Aug; 71(8):2113-7. PubMed ID: 27118782
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Rapid inversion of the prevalences of macrolide resistance phenotypes paralleled by a diversification of T and emm types among Streptococcus pyogenes in Portugal.
    Silva-Costa C; Ramirez M; Melo-Cristino J;
    Antimicrob Agents Chemother; 2005 May; 49(5):2109-11. PubMed ID: 15855540
    [TBL] [Abstract][Full Text] [Related]  

  • 16. High macrolide resistance in Streptococcus pyogenes strains isolated from children with pharyngitis in China.
    Liu X; Shen X; Chang H; Huang G; Fu Z; Zheng Y; Wang L; Li C; Liu L; Shen Y; Yang Y
    Pediatr Pulmonol; 2009 May; 44(5):436-41. PubMed ID: 19360846
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Macrolide resistance in Peptostreptococcus spp. mediated by ermTR: possible source of macrolide-lincosamide-streptogramin B resistance in Streptococcus pyogenes.
    Reig M; Galan J; Baquero F; Perez-Diaz JC
    Antimicrob Agents Chemother; 2001 Feb; 45(2):630-2. PubMed ID: 11158770
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Antimicrobial susceptibility and macrolide resistance genes in Streptococcus pyogenes collected in Austria and Hungary.
    Gattringer R; Sauermann R; Lagler H; Stich K; Buxbaum A; Graninger W; Georgopoulos A
    Int J Antimicrob Agents; 2004 Sep; 24(3):290-3. PubMed ID: 15325435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Predominant role of msr(D) over mef(A) in macrolide resistance in Streptococcus pyogenes.
    Zhang Y; Tatsuno I; Okada R; Hata N; Matsumoto M; Isaka M; Isobe KI; Hasegawa T
    Microbiology (Reading); 2016 Jan; 162(1):46-52. PubMed ID: 26531240
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of Streptococcus pyogenes from Animal Clinical Specimens, Spain.
    Vela AI; Villalón P; Sáez-Nieto JA; Chacón G; Domínguez L; Fernández-Garayzábal JF
    Emerg Infect Dis; 2017 Dec; 23(12):2013-2016. PubMed ID: 29148379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.